Peptide Academy · Approved peptides · Education only
Teriparatide: What FDA Approved, Explained Simply
By BioLabs Research · Peptide Academy › Approved Peptides
Bone isn't a dead scaffold. It is living tissue that is constantly being broken down and rebuilt. Most osteoporosis medicines work by slowing the breakdown side. Teriparatide is interesting because it works on the building side.
On this page we'll keep it simple: what teriparatide is, what it does according to the official FDA label, and exactly what FDA approved. Nothing here is advice on using a medicine. Approved medicines are prescribed by licensed clinicians, and the official label is always the controlling text.
What it is
Teriparatide is the first 34 amino acids of human parathyroid hormone (PTH). The full natural hormone has 84 amino acids, but the first 34 carry the part that binds the receptor. It is made with recombinant DNA technology.
What it does
Per section 12.1 of the FDA label, PTH is the main regulator of calcium and phosphate in bone and kidney. Teriparatide and the first 34 amino acids of PTH bind the same high-affinity receptors on cells. The label explains that teriparatide's effects on the skeleton depend on the pattern of exposure, and that under the labelled conditions it stimulates new bone formation by preferentially activating bone-forming cells (osteoblasts) over bone-resorbing cells (osteoclasts).
For a deeper dive, see the peer-reviewed review: Clin Ther 2004 — 'Teriparatide: a review' (PubMed 15262455).
What FDA approved
Labelled indication: Treatment of postmenopausal women with osteoporosis at high risk for fracture, or who have failed or are intolerant to other osteoporosis therapy; to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture; and treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy at high risk for fracture.
'High risk for fracture' is defined on the label (a history of osteoporotic fracture or multiple risk factors).
Regulatory status at a glance
| Item | Status | Source |
|---|---|---|
| Application | NDA 021318 | Drugs@FDA |
| Original approval date | November 26, 2002 | openFDA |
| Labelled indication | As quoted above | DailyMed |
| Boxed warning | None on the current label | DailyMed |
| 503A bulks list | Not applicable: this is an FDA-approved product | — |
A common misunderstanding
People often assume a hormone always does the same thing. The teriparatide label shows otherwise: the skeletal effect depends on the pattern of exposure. Same messenger, different rhythm, different result.
What FDA approval actually means
Here's the part most people get wrong. FDA approval is narrow. It covers a specific product, from a specific manufacturer, for a specific use, in a specific group of patients, with a specific label. The approval does not belong to the molecule floating around in the world. A chemical with the same name, sold by someone else for any other purpose, is not an approved drug. That's why we quote the label's own indication and nothing more.
How we checked these facts
Every regulatory fact on this page comes from an official U.S. government source: the Drugs@FDA database (and its openFDA API) for the application number and approval date, and the current FDA label on DailyMed for the indication, boxed warning and mechanism. Mechanism background also comes from a peer-reviewed review indexed in PubMed. We don't reproduce usage instructions from labels. This is an education page, not a guide to using any medicine.
Why approved peptides matter for peptide science
Approved peptides prove that peptide research can turn into real medicines. They also show how high the bar is: controlled human trials, manufacturing inspections, a written label, and safety monitoring that continues after approval. Most peptides you read about online never got anywhere near that bar. Chapter 7 of the Academy explains where the line sits.
FAQ
Is teriparatide the whole parathyroid hormone?
No. It is the first 34 of PTH's 84 amino acids.
Does the current label carry a boxed warning?
No. The current FDA label on DailyMed has no boxed warning.
Is this page medical advice?
No. It is education only. Talk to a licensed healthcare professional about any medicine.
References: Drugs@FDA; openFDA; DailyMed label; PubMed review.